Antler Closes $72M SEA Fund II, Investing in 45 Startups Across Southeast Asia

Date:

Antler Closes US$72 Million SEA Fund II to Fuel Early-Stage Startups

Antler, a global early-stage venture capital firm, has announced the successful closure of its second Southeast Asia fund, Antler SEA Fund II, at US$72 million (RM324 million). This fund will focus on investing in early-stage, tech-enabled companies across Southeast Asia, providing essential pre-launch, pre-seed, and seed capital.

Over the coming months, Antler SEA Fund II plans to invest $27 million (over MYR 124 million) in 45 early-stage startups, including those emerging from the Antler Residency Programs held across Southeast Asia, with a specific allocation of $3 million (over MYR 13 million) for Malaysia.

The Antler Residency Program is open to early-stage startups with co-founders and individuals with the potential to become founders. Participants in the program gain access to a community of entrepreneurs, expertise-building opportunities, a global network of institutional investors, and capital from day one. The next cohort for Malaysia is set to begin in October 2024.

Antler Malaysia recently launched its second cohort in July 2024, welcoming 68 experienced and diverse founders to the program. The fund has already invested in promising companies in Malaysia, including Biogenes Technologies, COEX, and MessengerCo.

Jussi Salovaara, Co-founder and Managing Partner of Antler, emphasized that Antler SEA Fund II marks a significant step in supporting founders from inception through their growth journey. The fund is backed by global and regional limited partners, including institutional investors, sovereign wealth funds, pension funds, and university endowments.

The closure of the fund reflects a growing interest in early-stage investments, driven by digitalization, a rising middle class, and robust economic growth in the region. Antler has also introduced ARC (Agreement for Rolling Capital), a fundraising initiative for early-stage founders to secure up to US$600,000 within the first nine months of their company’s lifecycle.

See also  New Research Aims to Revolutionize Endometriosis Management, New Zealand

Additionally, Antler will continue to invest in growth-stage startups through its emerging growth fund, Antler Elevate, with a focus on providing scale-up capital for companies from Series A onwards. The fund globally invests in breakout companies across various industries and technologies.

Antler Malaysia is currently accepting applications for its third cohort starting in October 2024. Startups and aspiring entrepreneurs are encouraged to apply for funding and support through the Antler Residency Program to build impactful companies for the future.

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Advait Gupta
Advait Gupta
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.